HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s Warning To Lash-Growth Firm Shows Risks In Third-Party Claims

This article was originally published in The Rose Sheet

Executive Summary

An April 18 FDA warning letter to Lifetech Resources LLC demonstrates that cosmetics firms will be held accountable when their websites feature third-party claims and testimonials that cross into drug marketing territory.

You may also be interested in...



Cosmeceuticals During COVID: New Natural Infusions, Same Regulatory Jungle

Consumers with time on their hands at home have become better researched about plant-derived ingredients that deliver results, which, according to Lodaat Pharmaceuticals, is where cosmeceuticals are headed. Cosmeceutical possibilities and regulatory complexities were the substance of a panel discussion at CPhI Worldwide, featuring Lodaat director Rajiv Khatau and EAS Consulting’s John Bailey.

Rodan + Fields Prostaglandin Lash Boost Suit Appears Headed For Settlement

The San Francisco-based multi-level beauty marketer seems intent on putting an end to a multi-year, consolidated putative class action in California federal court alleging it failed to disclose risks associated with the prostaglandin analog in its Lash Boost conditioning serum.

European Commission Examining Prostaglandins In Cosmetics: Are They Safe? Are They Drugs?

Marketers of cosmetic products that rely on prostaglandins or their analogues to grow eyelashes – or compete against companies that use the ingredients – have until 22 October to submit information to the Commission, which will help inform an assessment by the Scientific Committee on Consumer Safety.

Related Content

UsernamePublicRestriction

Register

RS017546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel